These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9809901)

  • 1. Proarrhythmia.
    Friedman PL; Stevenson WG
    Am J Cardiol; 1998 Oct; 82(8A):50N-58N. PubMed ID: 9809901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
    Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
    J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmia.
    Naccarelli GV; Wolbrette DL; Luck JC
    Med Clin North Am; 2001 Mar; 85(2):503-26, xii. PubMed ID: 11233957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proarrhythmia in patients treated for atrial fibrillation or flutter.
    Falk RH
    Ann Intern Med; 1992 Jul; 117(2):141-50. PubMed ID: 1605429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmia: a paradoxic response to antiarrhythmic agents.
    McCollam PL; Parker RB; Beckman KJ; Hariman RJ; Bauman JL
    Pharmacotherapy; 1989; 9(3):144-53. PubMed ID: 2666959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and management of proarrhythmia.
    Roden DM
    Am J Cardiol; 1998 Aug; 82(4A):49I-57I. PubMed ID: 9737654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR
    Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias.
    Brembilla-Perrot B; Houriez P; Beurrier D; Claudon O; Terrier de la Chaise A; Louis P
    Int J Cardiol; 2001 Aug; 80(1):7-15. PubMed ID: 11532541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide-associated bradycardia-dependent torsade de pointes: another potential mechanism of proarrhythmia.
    Kim HS; Pak HN; Park JS; Kim SS
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e84-6. PubMed ID: 21029131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
    Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
    Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes.
    Reiffel JA
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):877-9. PubMed ID: 16105020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety considerations in the pharmacological management of atrial fibrillation.
    Camm AJ
    Int J Cardiol; 2008 Jul; 127(3):299-306. PubMed ID: 18191470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics and management of proarrhythmias during antiarrhythmic therapy].
    Kobayashi Y
    Nihon Rinsho; 2013 Jan; 71(1):79-85. PubMed ID: 23631176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.